{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:09:46Z","timestamp":1788217786885,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014450","name":"University of Colorado Anschutz Medical Campus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014450","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.contraception.2024.110442","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T17:28:26Z","timestamp":1711560506000},"page":"110442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-8450","authenticated-orcid":false,"given":"Cara","family":"Clure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanelle","family":"Sheeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Lazorwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2024.110442_bib1","unstructured":"Daniels K,\u00a0Daugherty J, Jones J.\u00a0Current contraceptive status among women aged 15-44: United States, 2011-2013. NCHS data brief.\u00a02014;173:1\u20138."},{"key":"10.1016\/j.contraception.2024.110442_bib2","series-title":"Contraceptive technology","author":"Hatcher","year":"2011"},{"key":"10.1016\/j.contraception.2024.110442_bib3","unstructured":"U.S. Food and Drug Administration Prescribing Information. Nexplanon (etonogestrel implant). Reference ID: 3808594; 2001. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/021529s011lbl.pdf\u3009, 2019\u00a0(accessed December 29,\u00a02023)."},{"key":"10.1016\/j.contraception.2024.110442_bib4","unstructured":"Merck. Nexplanon Mandatory Training Module Completion. 2018. \u3008https:\/\/www.wvdhhr.org\/fp\/files\/Nexplanon_Mandatory_Update_Training.pdf\u3009, 2019. (accessed December 29, 2023)."},{"issue":"1","key":"10.1016\/j.contraception.2024.110442_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2019.02.007","article-title":"Neurovascular anatomy of the adult female medial arm in relationship to potential sites for insertion of the etonogestrel contraceptive implant","volume":"100","author":"Iwanaga","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110442_bib6","first-page":"57","article-title":"Percutaneous extraction of an embolized progesterone contraceptive implant from the pulmonary artery","volume":"9","author":"Akhtar","year":"2018","journal-title":"Open Access\u00a0J\u00a0Contracept"},{"issue":"6","key":"10.1016\/j.contraception.2024.110442_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2017.08.009","article-title":"Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database","volume":"96","author":"Kang","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110442_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40834-018-0070-0","article-title":"Peripheral nerve injury with Nexplanon removal: case report and review of the literature","volume":"3","author":"Lefebvre","year":"2018","journal-title":"Contraception\u00a0Reprod Med"},{"key":"10.1016\/j.contraception.2024.110442_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2021.10.002","article-title":"Localization and management of nonpalpable radiopaque contraceptive implant","volume":"106","author":"Kwal","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110442_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejogrb.2018.03.051","article-title":"Alternative insertion site in the scapular region for etonogestrel contraceptive implant (Nexplanon((R))","volume":"224","author":"Pragout","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.contraception.2024.110442_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/AOG.0000000000002777","article-title":"Provision of moderately and highly effective reversible contraception to insured women with intellectual and developmental disabilities","volume":"132","author":"Wu","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2024.110442_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.2020.20020154","article-title":"Contraception for women with psychiatric disorders","volume":"178","author":"McCloskey","year":"2021","journal-title":"Am J Psych"},{"key":"10.1016\/j.contraception.2024.110442_bib13","series-title":"GeneReviews\u00ae [Internet]","article-title":"Dystrophinopathies","author":"Darras","year":"2000"},{"key":"10.1016\/j.contraception.2024.110442_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0010-7824(98)00110-3","article-title":"Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon","volume":"58","author":"Wenzl","year":"1998","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2024.110442_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jpag.2018.02.032","article-title":"Novel location of nexplanon placement in developmentally delayed twins: a case report","volume":"31","author":"Quinlan","year":"2018","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"8","key":"10.1016\/j.contraception.2024.110442_bib16","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s11999-008-0635-3","article-title":"Vulnerable neurovasculature with a posterior approach to the scapula","volume":"467","author":"Wijdicks","year":"2009","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"10.1016\/j.contraception.2024.110442_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.contraception.2017.03.004","article-title":"The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users","volume":"95","author":"Lazorwitz","year":"2017","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2024.110442_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2024.110442_bib19","unstructured":"U.S. Food and Drug Administration. Drug development and drug interactions: table of substrates, inhibitors, and inducers. \u3008https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers\u3009\u00a0(accessed December\u00a029, 2023)."},{"issue":"6","key":"10.1016\/j.contraception.2024.110442_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/FTD.0b013e31829a10fa","article-title":"A UPLC-MS\/MS method for therapeutic drug monitoring of etonogestrel","volume":"35","author":"Thomas","year":"2013","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.contraception.2024.110442_bib21","unstructured":"U.S. Food and Drug Administration. Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs - General Considerations; 2014. \u3008https:\/\/www.fda.gov\/media\/88254\/download\u3009. (accessed December 29, 2023)."},{"issue":"3","key":"10.1016\/j.contraception.2024.110442_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1345\/aph.10149","article-title":"Implanon: a critical review","volume":"35","author":"Le","year":"2001","journal-title":"Ann Pharmacother"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T21:35:04Z","timestamp":1717191304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782424001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"alternative-id":["S0010782424001057"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110442","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110442"}}